A multicenter international randomized phase III study comparing cisplatin in combination with irinotecan or etoposide in previously untreated small-cell lung cancer patients with extensive disease

P. Zatloukal; F. Cardenal; A. Szczesna; V. Gorbunova; V. Moiseyenko; X. Zhang; L. Cisar; J.-C. Soria; M. Domine; M. Thomas

doi:10.1093/annonc/mdq036

A multicenter international randomized phase III study comparing cisplatin in combination with irinotecan or etoposide in previously untreated small-cell lung cancer patients with extensive disease

Annals of Oncology ◽

10.1093/annonc/mdq036 ◽

2010 ◽

Vol 21 (9) ◽

pp. 1810-1816 ◽

Cited By ~ 76

Author(s):

P. Zatloukal ◽

F. Cardenal ◽

A. Szczesna ◽

V. Gorbunova ◽

V. Moiseyenko ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Cell Lung Cancer ◽

Small Cell ◽

Phase Iii ◽

Small Cell Lung ◽

Extensive Disease ◽

Lung Cancer Patients ◽

Phase Iii Study

Download Full-text

Phase III study in stage IV non-small-cell lung cancer patients treated with two courses of cisplatin/gemcitabine followed by a randomization to three additional courses of the same combination or gemcitabine alone

Annals of Oncology ◽

10.1093/annonc/mdm061 ◽

2007 ◽

Vol 18 (5) ◽

pp. 903-908 ◽

Cited By ~ 14

Author(s):

S. Novello ◽

P. Bruzzi ◽

C. Barone ◽

R. Buosi ◽

A. Masotti ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Cell Lung Cancer ◽

Stage Iv ◽

Small Cell ◽

Phase Iii ◽

Small Cell Lung ◽

Lung Cancer Patients ◽

Phase Iii Study

Download Full-text

Disease Control as a Predictor of Survival with Gefitinib and Docetaxel in a Phase III Study (V-15-32) in Advanced Non-small Cell Lung Cancer Patients

Journal of Thoracic Oncology ◽

10.1097/jto.0b013e3181da36db ◽

2010 ◽

Vol 5 (7) ◽

pp. 1042-1047 ◽

Cited By ~ 6

Author(s):

Nobuyuki Yamamoto ◽

Yutaka Nishiwaki ◽

Shunichi Negoro ◽

Haiyi Jiang ◽

Yohji Itoh ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Disease Control ◽

Cancer Patients ◽

Cell Lung Cancer ◽

Small Cell ◽

Phase Iii ◽

Small Cell Lung ◽

Lung Cancer Patients ◽

Phase Iii Study

Download Full-text

Japanese subgroup analysis of a phase III study of S-1 versus docetaxel in non-small cell lung cancer patients after platinum-based treatment: EAST-LC

International Journal of Clinical Oncology ◽

10.1007/s10147-019-01396-z ◽

2019 ◽

Vol 24 (5) ◽

pp. 485-493

Author(s):

Shunichi Sugawara ◽

Kazuhiko Nakagawa ◽

Nobuyuki Yamamoto ◽

Hiroshi Nokihara ◽

Yuichiro Ohe ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Cell Lung Cancer ◽

Subgroup Analysis ◽

Small Cell ◽

Phase Iii ◽

Small Cell Lung ◽

Lung Cancer Patients ◽

Phase Iii Study

Download Full-text

Open-Label, Multicenter, Randomized, Phase III Study Comparing Oral Topotecan/Cisplatin Versus Etoposide/Cisplatin As Treatment for Chemotherapy-Naive Patients With Extensive-Disease Small-Cell Lung Cancer

Yearbook of Oncology ◽

10.1016/s1040-1741(08)70428-7 ◽

2007 ◽

Vol 2007 ◽

pp. 215-216

Author(s):

N.H. Hanna

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell ◽

Phase Iii ◽

Small Cell Lung ◽

Open Label ◽

Extensive Disease ◽

Phase Iii Study ◽

Oral Topotecan

Download Full-text

Efficacy and risk of cytotoxic chemotherapy in extensive disease-small cell lung cancer patients with interstitial pneumonia

BMC Cancer ◽

10.1186/s12885-019-5367-0 ◽

2019 ◽

Vol 19 (1) ◽

Cited By ~ 1

Author(s):

Masayuki Shirasawa ◽

Tomoya Fukui ◽

Seiichiro Kusuhara ◽

Yasuhiro Hiyoshi ◽

Yoshiro Nakahara ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Interstitial Pneumonia ◽

Cell Lung Cancer ◽

Cytotoxic Chemotherapy ◽

Small Cell ◽

Small Cell Lung ◽

Extensive Disease ◽

Lung Cancer Patients

Download Full-text

GLOB-1: a prospective randomised clinical phase III trial comparing vinorelbine–cisplatin with vinorelbine–ifosfamide–cisplatin in metastatic non-small-cell lung cancer patients

Annals of Oncology ◽

10.1093/annonc/mdf316 ◽

2002 ◽

Vol 13 (12) ◽

pp. 1853-1861 ◽

Cited By ~ 44

Author(s):

P.J. Souquet ◽

E.H. Tan ◽

J. Rodrigues Pereira ◽

R. Van Klaveren ◽

A. Price ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Cell Lung Cancer ◽

Small Cell ◽

Phase Iii ◽

Small Cell Lung ◽

Phase Iii Trial ◽

Lung Cancer Patients ◽

Clinical Phase

Download Full-text

A Randomized Phase III Study of Single-Agent Amrubicin Vs. Carboplatin/Etoposide in Elderly Patients With Extensive-Disease Small-Cell Lung Cancer

Clinical Lung Cancer ◽

10.1016/j.cllc.2013.11.006 ◽

2014 ◽

Vol 15 (2) ◽

pp. 96-102 ◽

Cited By ~ 15

Author(s):

Ikuo Sekine ◽

Hiroaki Okamoto ◽

Takeshi Horai ◽

Kazuhiko Nakagawa ◽

Hironobu Ohmatsu ◽

...

Keyword(s):

Lung Cancer ◽

Elderly Patients ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Single Agent ◽

Small Cell ◽

Phase Iii ◽

Small Cell Lung ◽

Extensive Disease ◽

Phase Iii Study

Download Full-text

Randomized Phase III Trial of Gefitinib versus Docetaxel in Non-Small Cell Lung Cancer Patients Who Have Previously Received Platinum-Based Chemotherapy

Clinical Cancer Research ◽

10.1158/1078-0432.ccr-09-1903 ◽

2010 ◽

Vol 16 (4) ◽

pp. 1307-1314 ◽

Cited By ~ 123

Author(s):

D. H. Lee ◽

K. Park ◽

J. H. Kim ◽

J.-S. Lee ◽

S. W. Shin ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Cell Lung Cancer ◽

Small Cell ◽

Phase Iii ◽

Small Cell Lung ◽

Phase Iii Trial ◽

Lung Cancer Patients ◽

Platinum Based Chemotherapy

Download Full-text

Comparing the adverse effects of platinum in combination with etoposide or irinotecan in previously untreated small-cell lung cancer patients with extensive disease: A network meta-analyses

Thoracic Cancer ◽

10.1111/1759-7714.12420 ◽

2017 ◽

Vol 8 (3) ◽

pp. 170-180 ◽

Cited By ~ 1

Author(s):

Yujie Chen ◽

Lingxiao Chen ◽

Diansheng Zhong

Keyword(s):

Lung Cancer ◽

Adverse Effects ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Cell Lung Cancer ◽

Small Cell ◽

Small Cell Lung ◽

Extensive Disease ◽

Lung Cancer Patients ◽

Meta Analyses

Download Full-text

P-795 Phase III study comparing cyclophosphamide, doxorubicin, and etoposide (CDE) to carboplatin and paclitaxel (CP) in patients (pts) with extensive disease small cell lung cancer (ED SCLC)

Lung Cancer ◽

10.1016/s0169-5002(05)81288-7 ◽

2005 ◽

Vol 49 ◽

pp. S328 ◽

Cited By ~ 1

Author(s):

E. Smit ◽

H. Groen ◽

B. Biesma ◽

C. vd Wilt ◽

M. Koolen ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell ◽

Phase Iii ◽

Small Cell Lung ◽

Extensive Disease ◽

Phase Iii Study

Download Full-text